KDR and osteosarcoma: We mainly addressed three aspects in this study: (1) VEGFR2 expression in primary and metastatic osteosarcoma; (2) significance of VEGFR2 inhibition to migration and invasion of osteosarcoma cells both in vivo and in vitro; and (3) possible mechanism of osteosarcoma metastasis mediated by VEGFR2.